The report "Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End User (Hospitals, Clinics) - Global Forecast to 2030" The Veterinary Vaccines industry is projected to grow from USD 11.63 billion in 2025 and to reach USD 16.15 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Browse 302 market data Tables and 60 Figures spread through 450 Pages and in-depth TOC on "Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End User (Hospitals, Clinics) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html
Globally, the growing awareness of animal health, increasing pet population and pet ownership, initiatives by various governments to improve animal health, and growing adoption of pet insurance policies are propelling the adoption of veterinary vaccines. A large number of pet owners, especially in major markets across North America and Europe, are purchasing pet insurance because of the significant growth in pet care expenditure in recent years.
Moreover, the increasing focus on new and advanced product development and growing adoption of veterinary vaccines in emerging economies are expected to support the veterinary vaccines market growth during the forecast period.
However, the high cost associated with vaccines is likely to hamper the growth of the veterinary vaccines market.
The companion animal vaccines segment is expected to register the highest growth rate in the global veterinary vaccines market.
Based on type, the companion animal vaccines market is growing significantly, driven by increasing pet ownership, heightened awareness of preventive healthcare, and the development of more effective and safer vaccines. As pets are increasingly viewed as family members, the demand for vaccinations to protect them from infectious diseases is rising. The growing recognition of zoonotic disease risks, government regulations, and the rise of pet insurance are further boosting vaccine demand. Additionally, emerging markets, particularly in Asia Pacific, are contributing to this growth as disposable incomes rise and more pet owners seek veterinary care.
The veterinary hospitals segment is anticipated to grow at a significant rate in the veterinary vaccines market during the forecast period.
Based on application, the veterinary hospitals segment is growing quickly as more pet owners seek professional care for their pets. With pets being treated like family, owners turn to veterinary hospitals for vaccinations and overall health care. These hospitals offer advanced vaccines and follow-up care, making them a go-to choice for ensuring pets stay healthy. Partnerships with pharmaceutical companies and the growing focus on preventive care are also helping drive this growth. As a result, veterinary hospitals are becoming an increasingly important part of the pet healthcare landscape.
The Asia Pacific market, by region, is expected to register the highest growth rate during the forecast period.
The veterinary vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is experiencing rapid growth in the veterinary vaccines market, driven by rising pet ownership, increasing awareness of pet health, and growing disposable incomes. As more people in countries like China, India, and Southeast Asia adopt pets, there is a rising demand for veterinary care, including vaccinations. The expansion of veterinary hospitals, along with government initiatives to improve animal health and prevent zoonotic diseases, is further boosting vaccine adoption. This combination of factors makes Asia Pacific one of the fastest-growing regions in the veterinary vaccines market.
As of 2025, the veterinary vaccines market was dominated by Zoetis (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco (US), Virbac (France), Ceva (France), Phibro Animal Health Corporation (US), Hester Biosciences Limited (India), Neogen Corporation (US), HIPRA (Spain), and Biogénesis Bagó (Argentina), among others.
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com